2011 RD 
2012 ME 
2013 MH 
2014 OPTIC PIT 
2015 CSCR 
2016 FLOATERS 
2017 ENDOPHTHALMITIS 
http://www.evrs.eu/medias/2010/videos/PeterStalmans_VP6_768K.flv Peter Stalmans (Leuven, Belgium) Advantages: Vitreo macular adhesion can cause significant distortion of the normal macular anatomy, resulting in decreased visual function, and can lead to macular hole formation, or enhance other diseases such as diabetic maculopathy or age related macular degeneration. Release of the vitreo macular adhesion can restore the macular anatomy,...
Read MoreRecovery of Macular Anatomy after Release of Vitreo Macular Adhesion Using Microplasmin
Posted by Peter Stalmans on Oct 1, 2010 in enzymatic vitreolysis
Evolving Concepts in Pharmacologic Vitreolysis
Posted by Brooks W. McCuen on Oct 1, 2006 in enzymatic vitreolysis, Internal limiting membrane, Posterior hyaloid
Brooks W. McCuen, II, MD (Durham, NC) The attachment of the cortical vitreous to the inner limiting lamina of the retinal surface plays an important role in the pathophysiology of many vitreoretinal diseases, such as idiopathic macular hole, vitreomacular traction syndrome, penetrating ocular trauma and proliferative diabetic retinopathy. Despite continued improvement in techniques and instrumentation, achieving an atraumatic cleavage of...
Read MoreA Simple Predictor of Vitrase® Efficacy for Successful Laser Treatment in Patients with Diabetes and Severe Vitreous Hemorrhage
Posted by Abdhish R. Bhavsar, Maurice B. Landers, Ronald K. Pearson, Alan M. Hochberg, Timothy R. McNamara, James A. Gow and Lisa R. Grillone on Oct 1, 2006 in Diabetes mellitus, enzymatic vitreolysis, intravitreal haemorrhage, Pan retinal photocoagulation
Abdhish R. Bhavsar, MD (Minneapolis, MN),* Maurice B. Landers, MD, FACS (Chapel Hill, NC),* Ronald K. Pearson, PhD (Harrisburg, PA),* Alan M. Hochberg, BSE (Harrisburg, PA),* Timothy R. McNamara, Pharm D (Irvine, CA),* James A. Gow, MD (Irvine, CA),* Lisa R. Grillone, PhD (Irvine, CA)* PURPOSE: To develop and validate a method of predicting by one month post-intravitreous injection whether subjects receiving Vitrase® (lyophilized, ovine...
Read MoreVitrase for Vitreous Hemorrhage Revisited
Posted by Michael A. Singer, Rafael Lin Wong, Catherine Alderete and Robin Hartman on Oct 1, 2006 in enzymatic vitreolysis, intravitreal haemorrhage
http://www.evrs.eu/medias/2006/congress/Vitrase-for-Vitreous-Hemorrhage-Revisited.swf Michael A. Singer, MD (San Antonio, TX), Rafael Lin Wong, (San Antonio, TX), Catherine Alderete, CMA (San Antonio, TX), Robin D. Hartman, BBA (San Antonio, TX) PURPOSE: To determine whether Vitrase is effective in clearing of vitreous hemorrhage and at what point in time hemorrhage clears enough to adequately assess pathology and...
Read MoreA Simple Predictor of Vitrase® Efficacy for BCVA Improvement in Patients with Diabetes and Severe Vitreous Hemorrhage
Posted by Abdhish R. Bhavsar, Maurice B. Landers, Ronald K. Pearson, Alan M. Hochberg, Timothy R. McNamara, James A. Gow and Lisa R. Grillone on Oct 1, 2006 in Diabetes mellitus, enzymatic vitreolysis, intravitreal haemorrhage
http://www.evrs.eu/medias/2006/congress/A-Simple-Predictor-of-Vitrase-Efficacy-for-BCVA-Improvement-in-Patients-with-Diabetes-and-Severe-Vitreous-Hemorrhage.swf Abdhish R. Bhavsar, MD (Minneapolis, MN),* Maurice B Landers, MD (Chapel Hill, NC),* Ronald K Pearson, (Harrisburg, PA),* Alan M. Hochberg, BSE (Harrisburg, PA),* Timothy R. McNamara, Pharm D (Irvine, CA),* James A. Gow, MD (Irvine, CA),* Lisa R. Grillone, PhD (Irvine,...
Read More